Breast cancer Avastin: Breast cancer Avastin treatment - mcall.com
Links shared publicly online about this topic.
- 655total visits
Breast cancer Avastin: Breast cancer Avastin treatment - mcall.com
View full resource at mcall.com
Tags: Cancer, Cancer Medication, Breast Cancer, Breast Cancer Medication, Drug, Women's Health, Avastin
Most Recently Shared on December 14, 2010 at 7:05 pm By:
You can help us get the word out about the importance of keeping a critical breast cancer drug on the market. http://ow.ly/3oX7w
Clifford A. Hudis, MD: The Value of Progression-Free Survival (PFS)
oncologytube.com — “Clifford A. Hudis, MD: The Value of Progression-Free Survival (PFS): Dr. Clifford Hudis, through his discussion of the trial showing bevacizumab (Avastin) slows metastatic breast cancer, he highlights the important topic of the value of progression-free survival (PFS)....” View full resource at oncologytube.com
Most Recently Shared on March 27, 2012 at 11:00 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
In this #video, Clifford A. Hudis, MD talks about the value of progression-free survival - via @oncologytube http://t.co/4NwbT48r
InVite Study in Metastatic Breast Cancer - 23andMe
23andme.com — “The InVite Study is a collaborative effort between 23andMe and Genentech to learn more about how genes influence response to bevacizumab (also known as Avastin?) in the treatment of metastatic breast cancer.” View full resource at 23andme.com
Most Recently Shared on March 21, 2012 at 12:33 pm By:
RT @23andme: 23andMe and Genentech have teamed up for a genetic study in metastatic breast cancer. For more info: http://t.co/y9x2SiXX
Nature News Blog: Genentech, 23andMe to study genetic response to breast cancer drug : Nature News Blog
blogs.nature.com — “Personal genomics company 23andMe and biotechnology firm Genentech are recruiting breast cancer patients to study genetic predictors of how well they respond to the drug Avastin. Read more” View full resource at blogs.nature.com
Most Recently Shared on March 21, 2012 at 12:09 pm By:
Anas Younes, M.D. Doctor, Internist, Oncologist, and Physician
should have been done earlier RT @natureblogs: Genentech, 23andMe to study genetic response to Avastin in breast cancer http://t.co/PVgNDQWa
Avastin Should Be Re-Approved For Breast Cancer - Forbes
forbes.com — “Could new studies provide the rationale for another accelerated approval of Avastin, this time for early stage breast cancer? We don’t see why not.” View full resource at forbes.com
Most Recently Shared on March 14, 2012 at 3:59 pm By:
Avastin Should Be Re-Approved For Breast Cancer: Could new studies provide the rationale for another accelerated... http://t.co/5NB0ZkdC
Avastin Should Be Re-Approved For Breast Cancer - Forbes
forbes.com — “Could new studies provide the rationale for another accelerated approval of Avastin, this time for early stage breast cancer? We don’t see why not.” View full resource at forbes.com
Most Recently Shared on March 14, 2012 at 3:50 pm By:
Drugs and Devices OW OW Health
Avastin Should Be Re-Approved For Breast Cancer: Could new studies provide the rationale for another accel... http://t.co/Kibev4Xh #drug
What Will CMS Do With Avastin In Breast Cancer? :: The RPM Report :: Elsevier Business Intelligence
elsevierbi.com — “What Will CMS Do With Avastin In Breast Cancer? :: The RPM Report :: Elsevier Business Intelligence” View full resource at elsevierbi.com
Most Recently Shared on February 28, 2012 at 3:23 pm By:
Ramsey Baghdadi Health Communicator
Getting an FDA adcomm = bad: http://t.co/hXxqt1SG and what CMS will do with Avastin in MBC: http://t.co/f1cwpvc0
What Will CMS Do With Avastin In Breast Cancer? :: The RPM Report :: Elsevier Business Intelligence
elsevierbi.com — “What Will CMS Do With Avastin In Breast Cancer? :: The RPM Report :: Elsevier Business Intelligence” View full resource at elsevierbi.com
Most Recently Shared on February 21, 2012 at 5:34 pm By:
Ramsey Baghdadi Health Communicator
What Will CMS Do With Avastin In Breast Cancer? (The RPM Report, subscribers): http://t.co/a409btA6
New Avastin tests add to confusion over use in breast cancer - latimes.com
latimes.com — “After the FDA pulled its approval for Avastin in metastatic breast cancer cases in November, a couple of new studies offer hints of hope for its use in early-stage breast cancer.” View full resource at latimes.com
Most Recently Shared on January 28, 2012 at 3:09 am By:
Breast Cancer News Health News
Google News: New Avastin tests add to confusion over use in breast cancer - Los Angeles: http://t.co/U49t1gMv Full http://t.co/sJPQq0Rn
Sometimes Science Is Not Convenient: Avastin® In The (Very) Early Treatment Of Breast Cancer
cancer.org — “Sometimes Science Is Not Convenient: Avastin® In The (Very) Early Treatment Of Breast Cancer” View full resource at cancer.org
Most Recently Shared on January 26, 2012 at 5:53 pm By:
Len Lichtenfeld Doctor, Internist, Oncologist, and Physician
Sometimes science is not convenient: Avastin in the very early treatment of breast cancer http://t.co/i2WBQd1x
Wendy Harpham on Healthy Survivorship: Revoking FDA Approval: Conclusion
wendyharpham.typepad.com — “The FDA revokes approval of Avastin for breast cancer. What's a survivor to do? Healthy Survivors look at things the way they are. Not the way they think things should...” View full resource at wendyharpham.typepad.com
Most Recently Shared on January 13, 2012 at 5:18 am By:
Wendy S. Harpham Doctor, Internist, and Physician
Revoking FDA Approval: Conclusion http://t.co/bZfNswwT
Wendy Harpham on Healthy Survivorship: Revoking Avastin: Right or Wrong? - Part IX
wendyharpham.typepad.com — “In my last post, I asked, "Why not, at least, make Avastin available to breast cancer patients who are doing well on it?" Arguments for: Patients should have the ultimate...” View full resource at wendyharpham.typepad.com
Most Recently Shared on January 10, 2012 at 9:49 pm By:
Wendy S. Harpham Doctor, Internist, and Physician
Revoking Avastin: Right or Wrong? - Part IX http://t.co/PorzMWo4
Avastin 'delays ovarian cancer growth' | News | Nursing Times
nursingtimes.net — “Women with advanced ovarian cancer may be offered new hope by Avastin’s ability to starve tumours of blood.” View full resource at nursingtimes.net
Most Recently Shared on January 8, 2012 at 12:55 am By:
News: Avastin 'delays ovarian cancer growth' http://t.co/YSTlVihE
Wendy Harpham on Healthy Survivorship: Revoking Avastin: Right or Wrong? - Part VIII
wendyharpham.typepad.com — “The case of the FDA revoking approval of Avastin for the treatment of breast cancer is complicated by the urgency of the need for better therapies. We’re not talking about...” View full resource at wendyharpham.typepad.com
Most Recently Shared on January 6, 2012 at 3:56 am By:
Wendy S. Harpham Doctor, Internist, and Physician
Revoking Avastin: Right or Wrong? - Part VIII http://t.co/flAJK3xb
Avastin | Dr. Michael Gazsi, Naturopathic Physician
drgazsi.com — “Avastin | Dr. Michael Gazsi, Naturopathic Physician” View full resource at drgazsi.com
Most Recently Shared on January 6, 2012 at 1:44 am By:
drgazsi CAM and Naturopathic Doctor
Blog post Avastin: The FDA recommends that doctors no longer use the drug Avastin to treat breast cancer. After ... http://t.co/AvlqzjYx
Avastin use in ovarian cancer may delay disease - Health - CBC News
cbc.ca — “A drug formerly used to treat advanced breast cancer slightly extend the lifespan of women with advanced ovarian cancer, new research suggests.” View full resource at cbc.ca
Most Recently Shared on December 30, 2011 at 5:56 pm By:
Joanna Lynn CAM and Nutritionist
Avastin use in ovarian cancer may delay disease http://t.co/DmaM2Q59
Advertisement
